Kura Oncology Cash Flow Statement (2010-2026) | KURA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)												-49.52M	-50.84M	-54.40M	-17.20M	-57.43M	-66.12M	-74.12M	197.37M	-73.33M
Depreciation and Depletion (Quarter)	0.12M	0.16M	0.17M	0.18M	0.18M	0.19M	0.25M	0.21M	0.21M	0.22M	0.17M	0.23M	0.20M	0.21M	0.16M	0.24M	0.22M	0.16M	0.40M	0.35M
Share-based Compensation (Quarter)	5.99M	6.11M	6.40M	6.65M	6.51M	6.36M	6.80M	6.84M	6.99M	7.09M	7.17M	8.51M	8.43M	8.32M	8.63M	7.84M	6.95M	10.96M	11.35M	8.42M
Gains from Sales and Divestitures (Quarter)																			0.40M
Gains from Investment Securities (Quarter)	1.59M	-0.43M	2.73M	-0.10M	0.11M	-0.23M	0.93M				10.30M				12.90M	1.16M	1.16M	0.97M	1.01M
Non-cash Items (Quarter)	58.50M	55.00M	3.15M	57.50M	53.20M	48.40M	4.41M	49.60M	45.40M	42.00M	5.96M	49.40M	49.00M	47.20M	7.71M	47.20M	43.70M	41.00M	36.60M	51.80M
Cash from Operations (Quarter)	-28.07M	-24.59M	-23.37M	-32.18M	-30.34M	-21.01M	-26.53M	-35.87M	-25.62M	-29.03M	-34.31M	-48.84M	-42.53M	-43.44M	269.13M	-71.93M	-28.78M	-80.63M	117.27M	-85.85M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.14M	-1.19M	-1.22M	-1.10M	-0.79M	-0.37M	0.65M	1.69M	2.11M	2.89M	2.73M	3.27M	3.55M	3.44M	2.88M	2.66M	2.52M	1.92M	1.38M	0.90M
Amortization of Deferred Charges (Quarter)								0.12M	0.12M	0.12M	0.12M	0.12M	0.13M	0.13M	0.14M	0.13M	0.14M	0.14M	0.10M	0.11M
Depreciation & Amortization (CF) (Quarter)	0.12M	0.16M	0.17M	0.18M	0.18M	0.19M	0.25M	0.21M	0.21M	0.22M	0.17M	0.23M	0.20M	0.21M	0.16M	0.24M	0.22M	0.16M	0.40M	0.35M
Change in Working Capital
Change in Receivables (Quarter)																46.69M	-44.17M	31.36M	-27.13M	0.54M
Change in Inventory (Quarter)																				0.43M
Change in Account Payables (Quarter)																3.14M				2.03M
Change in Accured Expenses (Quarter)	-1.24M	0.14M	0.03M	-5.25M	-0.34M	6.35M	-1.56M	-5.36M	4.11M	3.93M	8.57M	-3.13M	-0.05M	5.68M	14.33M	-8.61M	10.71M	12.72M	-2.16M	-16.22M
Investing Activities
Capital Expenditures (Quarter)	0.29M	0.72M	0.10M	0.05M	0.18M	0.38M	0.01M	0.04M	0.10M	0.02M	0.02M	0.08M	0.02M		0.37M	0.29M	1.46M	0.28M	4.61M	0.13M
Change in Acquisitions & Divestments (Quarter)	93.00M	99.50M	90.50M	26.49M	89.46M	129.14M	58.82M	85.00M	93.40M	105.25M	141.90M	99.81M	204.86M	107.26M	146.00M	167.60M	175.00M	235.03M	177.50M	147.50M
Cash from Investing Activities (Quarter)	-37.22M	22.55M	74.06M	-24.96M	33.10M	71.81M	-47.32M	11.13M	-46.33M	8.56M	42.20M	-95.34M	43.17M	45.53M	-94.95M	-101.41M	58.94M	93.97M	-64.60M	-24.23M
Financing Activities
Other financing activities (Quarter)	0.55M	2.26M	0.79M	0.30M	2.67M	0.88M	0.57M		0.43M	0.08M		2.56M	3.04M	2.20M	0.81M	0.14M	0.52M			0.07M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)	6.50M
Change in Capital Stock
Shares Issued (Quarter)	0.55M	2.26M	0.79M	0.30M	2.67M	0.88M	0.57M			0.08M	0.69M	2.56M	3.04M	2.20M	0.81M	0.14M	0.52M		1.14M	0.07M
Misc.
Cash from Financing Activities (Quarter)	-6.57M	2.26M	0.79M	0.30M	2.67M	0.88M	34.71M			0.08M	0.69M	148.37M	3.04M	2.20M	0.81M	0.14M	0.52M		1.14M	0.07M
Change in Cash (Quarter)	-71.86M	0.21M	51.49M	-56.84M	5.42M	51.68M	-39.13M	-24.74M	22.07M	-20.38M	8.58M	4.19M	3.68M	4.30M	174.98M	-173.19M	30.68M	13.34M	53.81M	-110.02M
Free Cash Flow (Quarter)	-28.36M	-25.32M	-23.47M	-32.23M	-30.52M	-21.39M	-26.54M	-35.91M	-25.71M	-29.05M	-34.32M	-48.93M	-42.55M	-43.44M	268.76M	-72.22M	-30.23M	-80.90M	112.66M	-85.98M
Net Cash Flow (Quarter)	-71.86M	0.21M	51.49M	-56.84M	5.42M	51.68M	-39.13M	-24.74M	-71.94M	-20.38M	8.58M	4.19M	3.68M	4.30M	174.98M	-173.19M	30.68M	13.34M	53.81M	-110.02M

Research Tools

Developers

Kura Oncology Cash Flow Statement (2010-2026) | KURA

Research Tools

Developers

Kura Oncology Cash Flow Statement (2010-2026) | KURA

Create an account

Sign In

Reset Password